Kelly McClintock

Kelly McClintock has extensive work experience in the scientific and laboratory research field. Kelly started their career as a Scientific Intern at The Scripps Research Institute in 2005, where they provided general support to various projects and maintained mice colonies used in experimental studies.

In 2008, Kelly joined the University of California Merced as an Assistant III, working on projects related to population structure, immune response, and DNA analysis. Kelly also served as a Remedial Tutor and Teaching Assistant, providing tutoring in math and science courses and managing student attendance and performance.

Moving on to Natera in 2013, Kelly held roles as a Clinical Laboratory Associate II Equipment QC and a Clinical Lab Associate II Lead. In these positions, they managed workflow, processed patient samples, performed molecular biology techniques, operated sequencing instruments, and organized presentations for team meetings.

Kelly then joined Roche Sequencing Solutions in 2016 as a Scientist II. Kelly aided in technology transfer and setup of the Roche San Jose CLIA lab, collaborated with multiple teams for assay implementation, and conducted hybrid based cfDNA oncology assays, data analysis, and quality control.

Currently, Kelly is working at GRAIL as an Associate Scientist. Their responsibilities include conducting scientific research and analysis, contributing to the development of new assays, and supporting the team in achieving their research objectives.

Throughout their career, Kelly has demonstrated strong technical skills, expertise in molecular biology techniques, and a dedication to contributing to scientific advancements in the field.

Kelly McClintock earned a Bachelors degree in Molecular Biology from the University of California, Merced, which they attended from 2006 to 2010. Kelly then pursued a Masters degree in Quantitative and Systems Biology from the same university, from 2010 to 2012.